Cite
de Luca XM, Newell F, Kazakoff SH, et al. Using whole-genome sequencing data to derive the homologous recombination deficiency scores. NPJ Breast Cancer. 2020;6:33doi: 10.1038/s41523-020-0172-0.
de Luca, X. M., Newell, F., Kazakoff, S. H., Hartel, G., McCart Reed, A. E., Holmes, O., Xu, Q., Wood, S., Leonard, C., Pearson, J. V., Lakhani, S. R., Waddell, N., Nones, K., & Simpson, P. T. (2020). Using whole-genome sequencing data to derive the homologous recombination deficiency scores. NPJ breast cancer, 633. https://doi.org/10.1038/s41523-020-0172-0
de Luca, Xavier M, et al. "Using whole-genome sequencing data to derive the homologous recombination deficiency scores." NPJ breast cancer vol. 6 (2020): 33. doi: https://doi.org/10.1038/s41523-020-0172-0
de Luca XM, Newell F, Kazakoff SH, Hartel G, McCart Reed AE, Holmes O, Xu Q, Wood S, Leonard C, Pearson JV, Lakhani SR, Waddell N, Nones K, Simpson PT. Using whole-genome sequencing data to derive the homologous recombination deficiency scores. NPJ Breast Cancer. 2020 Aug 07;6:33. doi: 10.1038/s41523-020-0172-0. eCollection 2020. PMID: 32818150; PMCID: PMC7414867.
Copy
Download .nbib